HILSTharimmune Inc


$ 0.37 $ 0.00 (0.03 %)    

Wednesday, 01-May-2024 09:58:48 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 0.3776
$ 0.37
$ 0.00 x 0
$ 0.00 x 0
$ 0.37 - $ 0.37
$ 0.34 - $ 12.48
46,994
na
na
$ 0.23
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hillstream-biopharma-progressing-towards-acquiring-clinical-stage-asset-and-announces-corporate-name-change-to-tharimmune-stock-to-trade-on-nasdaq-under-thar-effective-sept-25

Expects to launch and complete a Phase 1 trial in Q4 2023Tharimmune to begin trading under new ticker, THAR, on Monday Septembe...

 why-tenon-medical-shares-are-trading-lower-by-34-here-are-20-stocks-moving-premarket

Gainers

 why-okta-shares-are-trading-higher-by-11-here-are-20-stocks-moving-premarket

Gainers

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 210 companies reached new 52-week lows.

 why-emergent-biosolutions-shares-are-trading-higher-by-16-here-are-20-stocks-moving-premarket

Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported...

 dawson-james-downgrades-hillstream-biopharma-to-neutral

Dawson James analyst Jason Kolbert downgrades Hillstream BioPharma (NASDAQ:HILS) from Buy to Neutral.

 hillstream-biopharma-announces-strategic-reprioritization-of-pipeline-to-targeting-her2her3-solid-tumors-via-bispecific-and-adc-antibodies-and-biologics

Lead bispecific antibody, HSB-3215 designed to target novel conformational epitopes on high value validated targets, HER2 and H...

 hillstream-biopharma-licenses-technology-to-develop-proprietary-her2-and-her3-antibody-drug-conjugates-against-drug-resistant-breast-lung-gastric-and-ovarian-cancers

Anti-HER2 and Anti-HER3 monoclonal antibodies designed to have a high drug-to-antibody ratio intended enhance the bystander kil...

 why-cineverse-shares-are-trading-lower-by-18-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artifici...

 why-dxc-technology-shares-are-trading-lower-by-around-5-here-are-20-stocks-moving-premarket

Gainers

 why-monro-shares-are-trading-lower-by-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.

 crude-oil-rises-25-chevron-tops-q1-expectations

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 200 points on Friday. The Dow traded up 0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION